rdc-DiagnosticReport-agp-report
{
},
{
}
]
},
{
},
{
}
]
},
},
},
},
{
}
]
},
{
}
],
}
},
{
},
{
}
]
},
},
},
},
{
}
]
},
{
}
],
}
},
{
},
{
}
]
},
},
}
},
{
},
{
}
]
},
},
}
},
{
},
]
},
},
}
},
{
},
]
},
},
}
},
{
},
{
"display": "Amount of time, in percent, as measured by CGM (continuous glucose monitor) device, spent above target glucose range, very high (TAR-VH >250 mg/dL (>13.9 mmol/L) (hyperglycemic) during reporting period"
}
]
},
},
}
},
{
},
{
"display": "Amount of time, in percent, as measured by CGM (continuous glucose monitor) device, spent above target glucose range, high (TAR-H) 181-250 mg/ dL (10.1-13.9 mmol/L) (hyperglycemic) during reporting period"
}
]
},
},
}
},
{
},
{
"display": "Amount of time, in percent, as measured by CGM (continuous glucose monitor) device, spent in target glucose range (70-180 mg/dL [3.9-10.0 mmol/L]) during reporting period. The primary goal for effective and safe glucose control is to increase the TIR whil"
}
]
},
},
}
},
{
},
{
"display": "Amount of time, in percent, as measured by CGM (continuous glucose monitor) device, spent below target glucose range, low (TBR-L) 54-69 mg/dL (3.0-3.8 mmol/L) (hypoglycemic) during reporting period"
}
]
},
},
}
},
{
},
{
"display": "Amount of time, in percent, as measured by CGM (continuous glucose monitor) device, spent below target glucose range, very low (TBR-VL) <54 mg/dL (<3.0 mmol/L) (hypoglycemic) during reporting period"
}
]
},
},
}
}
],
},
},
],
{
},
{
},
{
},
{
},
{
},
{
},
{
},
{
},
{
},
{
},
{
}
],
{
}
]
}
</meta>
<Observation>
</meta>
</extension>
</coding>
</code>
</subject>
</effectivePeriod>
</extension>
</origin>
</valueSampledData>
</device>
</Observation>
</contained>
<Observation>
</meta>
</extension>
</coding>
</code>
</subject>
</effectivePeriod>
</extension>
</origin>
</valueSampledData>
</device>
</Observation>
</contained>
<Observation>
</meta>
</coding>
</code>
</effectivePeriod>
</valueQuantity>
</Observation>
</contained>
<Observation>
</meta>
</coding>
</code>
</effectivePeriod>
</valueQuantity>
</Observation>
</contained>
<Observation>
</meta>
</coding>
</code>
</effectivePeriod>
</valueQuantity>
</Observation>
</contained>
<Observation>
</meta>
</coding>
</code>
</effectivePeriod>
</valueQuantity>
</Observation>
</contained>
<Observation>
</meta>
<display value="Amount of time, in percent, as measured by CGM (continuous glucose monitor) device, spent above target glucose range, very high (TAR-VH >250 mg/dL (>13.9 mmol/L) (hyperglycemic) during reporting period" />
</coding>
</code>
</effectivePeriod>
</valueQuantity>
</Observation>
</contained>
<Observation>
</meta>
<display value="Amount of time, in percent, as measured by CGM (continuous glucose monitor) device, spent above target glucose range, high (TAR-H) 181-250 mg/ dL (10.1-13.9 mmol/L) (hyperglycemic) during reporting period" />
</coding>
</code>
</effectivePeriod>
</valueQuantity>
</Observation>
</contained>
<Observation>
</meta>
<display value="Amount of time, in percent, as measured by CGM (continuous glucose monitor) device, spent in target glucose range (70-180 mg/dL [3.9-10.0 mmol/L]) during reporting period. The primary goal for effective and safe glucose control is to increase the TIR whil" />
</coding>
</code>
</effectivePeriod>
</valueQuantity>
</Observation>
</contained>
<Observation>
</meta>
<display value="Amount of time, in percent, as measured by CGM (continuous glucose monitor) device, spent below target glucose range, low (TBR-L) 54-69 mg/dL (3.0-3.8 mmol/L) (hypoglycemic) during reporting period" />
</coding>
</code>
</effectivePeriod>
</valueQuantity>
</Observation>
</contained>
<Observation>
</meta>
<display value="Amount of time, in percent, as measured by CGM (continuous glucose monitor) device, spent below target glucose range, very low (TBR-VL) <54 mg/dL (<3.0 mmol/L) (hypoglycemic) during reporting period" />
</coding>
</code>
</effectivePeriod>
</valueQuantity>
</Observation>
</contained>
</coding>
</code>
</subject>
</effectivePeriod>
</performer>
</performer>
</result>
</result>
</result>
</result>
</result>
</result>
</result>
</result>
</result>
</result>
</result>
</presentedForm>
</DiagnosticReport>
| DiagnosticReport |
| id : rdc-DiagnosticReport-agp-report |
| meta |
| profile : https://roche.com/fhir/iop/StructureDefinition/rdc-DiagnosticReport |
| status : final |
| code |
| coding |
| code : R7786-7 |
| system : https://roche.com/fhir/CodeSystem/general |
| display : CGM Ambulatory Glucose Profile (AGP) During Reporting Period |
| contained |
| id : Obs-1 |
| meta |
| profile : https://roche.com/fhir/iop/StructureDefinition/rdc-Observation-CGM |
| status : final |
| code |
| coding |
| code : 434910001 |
| system : http://snomed.info/sct |
| display : Interstitial fluid glucose concentration (observable entity) |
| subject |
| reference : Patient/34605fdc-74aa-4587-a5f0-92e6c5f64527 |
| effective |
| start : 2020-10-14T02:01:00+01:00 |
| end : 2020-10-14T02:06:00+01:00 |
| value |
| origin |
| value : 0 |
| code : mg/dL |
| system : http://unitsofmeasure.org |
| unit : mg/dL |
| interval : 60000 |
| intervalUnit : ms |
| dimensions : 1 |
| data : 100 99 89 89 |
| extension |
| url : https://roche.com/fhir/iop/StructureDefinition/ext-CGMFlags |
| value : HI; X; X; LO |
| extension |
| url : https://roche.com/fhir/iop/StructureDefinition/ext-CalibrationStatus |
| value : calibrated |
| device |
| reference : Device/6ae8bff3-910a-419d-96f6-de0e8fd1d64d |
| contained |
| id : Obs-2 |
| meta |
| profile : https://roche.com/fhir/iop/StructureDefinition/rdc-Observation-CGM |
| status : final |
| code |
| coding |
| code : 434910001 |
| system : http://snomed.info/sct |
| display : Interstitial fluid glucose concentration (observable entity) |
| subject |
| reference : Patient/34605fdc-74aa-4587-a5f0-92e6c5f64527 |
| effective |
| start : 2020-10-15T02:01:00+01:00 |
| end : 2020-10-15T02:06:00+01:00 |
| value |
| origin |
| value : 0 |
| code : mg/dL |
| system : http://unitsofmeasure.org |
| unit : mg/dL |
| interval : 60000 |
| intervalUnit : ms |
| dimensions : 1 |
| data : 100 99 89 89 |
| extension |
| url : https://roche.com/fhir/iop/StructureDefinition/ext-CGMFlags |
| value : HI; X; X; LO |
| extension |
| url : https://roche.com/fhir/iop/StructureDefinition/ext-CalibrationStatus |
| value : calibrated |
| device |
| reference : Device/6ae8bff3-910a-419d-96f6-de0e8fd1d64d |
| contained |
| id : Obs-3 |
| meta |
| profile : https://roche.com/fhir/iop/StructureDefinition/rdc-Observation-Report |
| status : final |
| code |
| coding |
| code : 97507-8 |
| system : http://loinc.org |
| display : Average glucose [Mass/ volume] in Interstitial fluid during Reporting Period |
| effective |
| start : 2020-10-15T02:01:00+01:00 |
| end : 2020-10-15T02:06:00+01:00 |
| value |
| system : http://unitsofmeasure.org |
| code : mg/dL |
| unit : mg/dL |
| value : 136 |
| contained |
| id : Obs-4 |
| meta |
| profile : https://roche.com/fhir/iop/StructureDefinition/rdc-Observation-Report |
| status : final |
| code |
| coding |
| code : R9599-2 |
| system : https://roche.com/fhir/CodeSystem/general |
| display : CGM Glycemic Variability (%GV), during reporting period |
| effective |
| start : 2020-10-15T02:01:00+01:00 |
| end : 2020-10-15T02:06:00+01:00 |
| value |
| system : http://unitsofmeasure.org |
| code : mg/dL |
| unit : mg/dL |
| value : 35.5 |
| contained |
| id : Obs-5 |
| meta |
| profile : https://roche.com/fhir/iop/StructureDefinition/rdc-Observation-Report |
| status : final |
| code |
| coding |
| code : 97504-5 |
| system : http://loinc.org |
| display : Percent sensor usage |
| effective |
| start : 2020-10-15T02:01:00+01:00 |
| end : 2020-10-15T02:06:00+01:00 |
| value |
| system : http://unitsofmeasure.org |
| code : % |
| unit : % |
| value : 100 |
| contained |
| id : Obs-6 |
| meta |
| profile : https://roche.com/fhir/iop/StructureDefinition/rdc-Observation-Report |
| status : final |
| code |
| coding |
| code : 97506-0 |
| system : http://loinc.org |
| display : Glucose management indicator |
| effective |
| start : 2020-10-15T02:01:00+01:00 |
| end : 2020-10-15T02:06:00+01:00 |
| value |
| system : http://unitsofmeasure.org |
| code : % |
| unit : % |
| value : 6.6 |
| contained |
| id : Obs-7 |
| meta |
| profile : https://roche.com/fhir/iop/StructureDefinition/rdc-Observation-Report |
| status : final |
| code |
| coding |
| code : 104639-0 |
| system : http://loinc.org |
| display : Amount of time, in percent, as measured by CGM (continuous glucose monitor) device, spent above target glucose range, very high (TAR-VH >250 mg/dL (>13.9 mmol/L) (hyperglycemic) during reporting period |
| effective |
| start : 2020-10-15T02:01:00+01:00 |
| end : 2020-10-15T02:06:00+01:00 |
| value |
| system : http://unitsofmeasure.org |
| code : % |
| unit : % |
| value : 3 |
| contained |
| id : Obs-8 |
| meta |
| profile : https://roche.com/fhir/iop/StructureDefinition/rdc-Observation-Report |
| status : final |
| code |
| coding |
| code : 104640-8 |
| system : http://loinc.org |
| display : Amount of time, in percent, as measured by CGM (continuous glucose monitor) device, spent above target glucose range, high (TAR-H) 181-250 mg/ dL (10.1-13.9 mmol/L) (hyperglycemic) during reporting period |
| effective |
| start : 2020-10-15T02:01:00+01:00 |
| end : 2020-10-15T02:06:00+01:00 |
| value |
| system : http://unitsofmeasure.org |
| code : % |
| unit : % |
| value : 14 |
| contained |
| id : Obs-9 |
| meta |
| profile : https://roche.com/fhir/iop/StructureDefinition/rdc-Observation-Report |
| status : final |
| code |
| coding |
| code : 97510-2 |
| system : http://loinc.org |
| display : Amount of time, in percent, as measured by CGM (continuous glucose monitor) device, spent in target glucose range (70-180 mg/dL [3.9-10.0 mmol/L]) during reporting period. The primary goal for effective and safe glucose control is to increase the TIR whil |
| effective |
| start : 2020-10-15T02:01:00+01:00 |
| end : 2020-10-15T02:06:00+01:00 |
| value |
| system : http://unitsofmeasure.org |
| code : % |
| unit : % |
| value : 78 |
| contained |
| id : Obs-10 |
| meta |
| profile : https://roche.com/fhir/iop/StructureDefinition/rdc-Observation-Report |
| status : final |
| code |
| coding |
| code : 104641-6 |
| system : http://loinc.org |
| display : Amount of time, in percent, as measured by CGM (continuous glucose monitor) device, spent below target glucose range, low (TBR-L) 54-69 mg/dL (3.0-3.8 mmol/L) (hypoglycemic) during reporting period |
| effective |
| start : 2020-10-15T02:01:00+01:00 |
| end : 2020-10-15T02:06:00+01:00 |
| value |
| system : http://unitsofmeasure.org |
| code : % |
| unit : % |
| value : 5 |
| contained |
| id : Obs-11 |
| meta |
| profile : https://roche.com/fhir/iop/StructureDefinition/rdc-Observation-Report |
| status : final |
| code |
| coding |
| code : 104642-4 |
| system : http://loinc.org |
| display : Amount of time, in percent, as measured by CGM (continuous glucose monitor) device, spent below target glucose range, very low (TBR-VL) <54 mg/dL (<3.0 mmol/L) (hypoglycemic) during reporting period |
| effective |
| start : 2020-10-15T02:01:00+01:00 |
| end : 2020-10-15T02:06:00+01:00 |
| value |
| system : http://unitsofmeasure.org |
| code : % |
| unit : % |
| value : 0 |
| subject |
| reference : Patient-Reference |
| effective |
| start : 2023-10-03T06:32:00+01:00 |
| end : 2023-10-03T07:30:00+01:00 |
| performer |
| reference : Organization-Reference |
| performer |
| reference : Practitioner-Reference |
| result |
| reference : #Obs-1 |
| result |
| reference : #Obs-2 |
| result |
| reference : #Obs-3 |
| result |
| reference : #Obs-4 |
| result |
| reference : #Obs-5 |
| result |
| reference : #Obs-6 |
| result |
| reference : #Obs-7 |
| result |
| reference : #Obs-8 |
| result |
| reference : #Obs-9 |
| result |
| reference : #Obs-10 |
| result |
| reference : #Obs-11 |
| presentedForm |
| url : https://aws-cloud-location-of-AGP-Report |
| data : QUdQIHJlcG9ydA== |
| hash : 2c9fa2fc8f4fd1b3184821e27dfc0b6960724633 |
| contentType : application/pdf |
| creation : 2023-10-03T07:30:00+01:00 |
| title : AGP-Report |
| DiagnosticReport.id[0] | rdc-DiagnosticReport-agp-report |
| DiagnosticReport.meta[0].profile[0] | https://roche.com/fhir/iop/StructureDefinition/rdc-DiagnosticReport |
| DiagnosticReport.contained[0].id[0] | Obs-1 |
| DiagnosticReport.contained[0].meta[0].profile[0] | https://roche.com/fhir/iop/StructureDefinition/rdc-Observation-CGM |
| DiagnosticReport.contained[0].extension[0].url[0] | https://roche.com/fhir/iop/StructureDefinition/ext-CalibrationStatus |
| DiagnosticReport.contained[0].extension[0].value[0] | calibrated |
| DiagnosticReport.contained[0].status[0] | final |
| DiagnosticReport.contained[0].code[0].coding[0].system[0] | http://snomed.info/sct |
| DiagnosticReport.contained[0].code[0].coding[0].code[0] | 434910001 |
| DiagnosticReport.contained[0].code[0].coding[0].display[0] | Interstitial fluid glucose concentration (observable entity) |
| DiagnosticReport.contained[0].subject[0].reference[0] | Patient/34605fdc-74aa-4587-a5f0-92e6c5f64527 |
| DiagnosticReport.contained[0].effective[0].start[0] | 2020-10-14T02:01:00+01:00 |
| DiagnosticReport.contained[0].effective[0].end[0] | 2020-10-14T02:06:00+01:00 |
| DiagnosticReport.contained[0].value[0].extension[0].url[0] | https://roche.com/fhir/iop/StructureDefinition/ext-CGMFlags |
| DiagnosticReport.contained[0].value[0].extension[0].value[0] | HI; X; X; LO |
| DiagnosticReport.contained[0].value[0].origin[0].value[0] | 0 |
| DiagnosticReport.contained[0].value[0].origin[0].unit[0] | mg/dL |
| DiagnosticReport.contained[0].value[0].origin[0].system[0] | http://unitsofmeasure.org |
| DiagnosticReport.contained[0].value[0].origin[0].code[0] | mg/dL |
| DiagnosticReport.contained[0].value[0].interval[0] | 60000 |
| DiagnosticReport.contained[0].value[0].intervalUnit[0] | ms |
| DiagnosticReport.contained[0].value[0].dimensions[0] | 1 |
| DiagnosticReport.contained[0].value[0].data[0] | 100 99 89 89 |
| DiagnosticReport.contained[0].device[0].reference[0] | Device/6ae8bff3-910a-419d-96f6-de0e8fd1d64d |
| DiagnosticReport.contained[1].id[0] | Obs-2 |
| DiagnosticReport.contained[1].meta[0].profile[0] | https://roche.com/fhir/iop/StructureDefinition/rdc-Observation-CGM |
| DiagnosticReport.contained[1].extension[0].url[0] | https://roche.com/fhir/iop/StructureDefinition/ext-CalibrationStatus |
| DiagnosticReport.contained[1].extension[0].value[0] | calibrated |
| DiagnosticReport.contained[1].status[0] | final |
| DiagnosticReport.contained[1].code[0].coding[0].system[0] | http://snomed.info/sct |
| DiagnosticReport.contained[1].code[0].coding[0].code[0] | 434910001 |
| DiagnosticReport.contained[1].code[0].coding[0].display[0] | Interstitial fluid glucose concentration (observable entity) |
| DiagnosticReport.contained[1].subject[0].reference[0] | Patient/34605fdc-74aa-4587-a5f0-92e6c5f64527 |
| DiagnosticReport.contained[1].effective[0].start[0] | 2020-10-15T02:01:00+01:00 |
| DiagnosticReport.contained[1].effective[0].end[0] | 2020-10-15T02:06:00+01:00 |
| DiagnosticReport.contained[1].value[0].extension[0].url[0] | https://roche.com/fhir/iop/StructureDefinition/ext-CGMFlags |
| DiagnosticReport.contained[1].value[0].extension[0].value[0] | HI; X; X; LO |
| DiagnosticReport.contained[1].value[0].origin[0].value[0] | 0 |
| DiagnosticReport.contained[1].value[0].origin[0].unit[0] | mg/dL |
| DiagnosticReport.contained[1].value[0].origin[0].system[0] | http://unitsofmeasure.org |
| DiagnosticReport.contained[1].value[0].origin[0].code[0] | mg/dL |
| DiagnosticReport.contained[1].value[0].interval[0] | 60000 |
| DiagnosticReport.contained[1].value[0].intervalUnit[0] | ms |
| DiagnosticReport.contained[1].value[0].dimensions[0] | 1 |
| DiagnosticReport.contained[1].value[0].data[0] | 100 99 89 89 |
| DiagnosticReport.contained[1].device[0].reference[0] | Device/6ae8bff3-910a-419d-96f6-de0e8fd1d64d |
| DiagnosticReport.contained[2].id[0] | Obs-3 |
| DiagnosticReport.contained[2].meta[0].profile[0] | https://roche.com/fhir/iop/StructureDefinition/rdc-Observation-Report |
| DiagnosticReport.contained[2].status[0] | final |
| DiagnosticReport.contained[2].code[0].coding[0].system[0] | http://loinc.org |
| DiagnosticReport.contained[2].code[0].coding[0].code[0] | 97507-8 |
| DiagnosticReport.contained[2].code[0].coding[0].display[0] | Average glucose [Mass/ volume] in Interstitial fluid during Reporting Period |
| DiagnosticReport.contained[2].effective[0].start[0] | 2020-10-15T02:01:00+01:00 |
| DiagnosticReport.contained[2].effective[0].end[0] | 2020-10-15T02:06:00+01:00 |
| DiagnosticReport.contained[2].value[0].value[0] | 136 |
| DiagnosticReport.contained[2].value[0].unit[0] | mg/dL |
| DiagnosticReport.contained[2].value[0].system[0] | http://unitsofmeasure.org |
| DiagnosticReport.contained[2].value[0].code[0] | mg/dL |
| DiagnosticReport.contained[3].id[0] | Obs-4 |
| DiagnosticReport.contained[3].meta[0].profile[0] | https://roche.com/fhir/iop/StructureDefinition/rdc-Observation-Report |
| DiagnosticReport.contained[3].status[0] | final |
| DiagnosticReport.contained[3].code[0].coding[0].system[0] | https://roche.com/fhir/CodeSystem/general |
| DiagnosticReport.contained[3].code[0].coding[0].code[0] | R9599-2 |
| DiagnosticReport.contained[3].code[0].coding[0].display[0] | CGM Glycemic Variability (%GV), during reporting period |
| DiagnosticReport.contained[3].effective[0].start[0] | 2020-10-15T02:01:00+01:00 |
| DiagnosticReport.contained[3].effective[0].end[0] | 2020-10-15T02:06:00+01:00 |
| DiagnosticReport.contained[3].value[0].value[0] | 35.5 |
| DiagnosticReport.contained[3].value[0].unit[0] | mg/dL |
| DiagnosticReport.contained[3].value[0].system[0] | http://unitsofmeasure.org |
| DiagnosticReport.contained[3].value[0].code[0] | mg/dL |
| DiagnosticReport.contained[4].id[0] | Obs-5 |
| DiagnosticReport.contained[4].meta[0].profile[0] | https://roche.com/fhir/iop/StructureDefinition/rdc-Observation-Report |
| DiagnosticReport.contained[4].status[0] | final |
| DiagnosticReport.contained[4].code[0].coding[0].system[0] | http://loinc.org |
| DiagnosticReport.contained[4].code[0].coding[0].code[0] | 97504-5 |
| DiagnosticReport.contained[4].code[0].coding[0].display[0] | Percent sensor usage |
| DiagnosticReport.contained[4].effective[0].start[0] | 2020-10-15T02:01:00+01:00 |
| DiagnosticReport.contained[4].effective[0].end[0] | 2020-10-15T02:06:00+01:00 |
| DiagnosticReport.contained[4].value[0].value[0] | 100 |
| DiagnosticReport.contained[4].value[0].unit[0] | % |
| DiagnosticReport.contained[4].value[0].system[0] | http://unitsofmeasure.org |
| DiagnosticReport.contained[4].value[0].code[0] | % |
| DiagnosticReport.contained[5].id[0] | Obs-6 |
| DiagnosticReport.contained[5].meta[0].profile[0] | https://roche.com/fhir/iop/StructureDefinition/rdc-Observation-Report |
| DiagnosticReport.contained[5].status[0] | final |
| DiagnosticReport.contained[5].code[0].coding[0].system[0] | http://loinc.org |
| DiagnosticReport.contained[5].code[0].coding[0].code[0] | 97506-0 |
| DiagnosticReport.contained[5].code[0].coding[0].display[0] | Glucose management indicator |
| DiagnosticReport.contained[5].effective[0].start[0] | 2020-10-15T02:01:00+01:00 |
| DiagnosticReport.contained[5].effective[0].end[0] | 2020-10-15T02:06:00+01:00 |
| DiagnosticReport.contained[5].value[0].value[0] | 6.6 |
| DiagnosticReport.contained[5].value[0].unit[0] | % |
| DiagnosticReport.contained[5].value[0].system[0] | http://unitsofmeasure.org |
| DiagnosticReport.contained[5].value[0].code[0] | % |
| DiagnosticReport.contained[6].id[0] | Obs-7 |
| DiagnosticReport.contained[6].meta[0].profile[0] | https://roche.com/fhir/iop/StructureDefinition/rdc-Observation-Report |
| DiagnosticReport.contained[6].status[0] | final |
| DiagnosticReport.contained[6].code[0].coding[0].system[0] | http://loinc.org |
| DiagnosticReport.contained[6].code[0].coding[0].code[0] | 104639-0 |
| DiagnosticReport.contained[6].code[0].coding[0].display[0] | Amount of time, in percent, as measured by CGM (continuous glucose monitor) device, spent above target glucose range, very high (TAR-VH >250 mg/dL (>13.9 mmol/L) (hyperglycemic) during reporting period |
| DiagnosticReport.contained[6].effective[0].start[0] | 2020-10-15T02:01:00+01:00 |
| DiagnosticReport.contained[6].effective[0].end[0] | 2020-10-15T02:06:00+01:00 |
| DiagnosticReport.contained[6].value[0].value[0] | 3 |
| DiagnosticReport.contained[6].value[0].unit[0] | % |
| DiagnosticReport.contained[6].value[0].system[0] | http://unitsofmeasure.org |
| DiagnosticReport.contained[6].value[0].code[0] | % |
| DiagnosticReport.contained[7].id[0] | Obs-8 |
| DiagnosticReport.contained[7].meta[0].profile[0] | https://roche.com/fhir/iop/StructureDefinition/rdc-Observation-Report |
| DiagnosticReport.contained[7].status[0] | final |
| DiagnosticReport.contained[7].code[0].coding[0].system[0] | http://loinc.org |
| DiagnosticReport.contained[7].code[0].coding[0].code[0] | 104640-8 |
| DiagnosticReport.contained[7].code[0].coding[0].display[0] | Amount of time, in percent, as measured by CGM (continuous glucose monitor) device, spent above target glucose range, high (TAR-H) 181-250 mg/ dL (10.1-13.9 mmol/L) (hyperglycemic) during reporting period |
| DiagnosticReport.contained[7].effective[0].start[0] | 2020-10-15T02:01:00+01:00 |
| DiagnosticReport.contained[7].effective[0].end[0] | 2020-10-15T02:06:00+01:00 |
| DiagnosticReport.contained[7].value[0].value[0] | 14 |
| DiagnosticReport.contained[7].value[0].unit[0] | % |
| DiagnosticReport.contained[7].value[0].system[0] | http://unitsofmeasure.org |
| DiagnosticReport.contained[7].value[0].code[0] | % |
| DiagnosticReport.contained[8].id[0] | Obs-9 |
| DiagnosticReport.contained[8].meta[0].profile[0] | https://roche.com/fhir/iop/StructureDefinition/rdc-Observation-Report |
| DiagnosticReport.contained[8].status[0] | final |
| DiagnosticReport.contained[8].code[0].coding[0].system[0] | http://loinc.org |
| DiagnosticReport.contained[8].code[0].coding[0].code[0] | 97510-2 |
| DiagnosticReport.contained[8].code[0].coding[0].display[0] | Amount of time, in percent, as measured by CGM (continuous glucose monitor) device, spent in target glucose range (70-180 mg/dL [3.9-10.0 mmol/L]) during reporting period. The primary goal for effective and safe glucose control is to increase the TIR whil |
| DiagnosticReport.contained[8].effective[0].start[0] | 2020-10-15T02:01:00+01:00 |
| DiagnosticReport.contained[8].effective[0].end[0] | 2020-10-15T02:06:00+01:00 |
| DiagnosticReport.contained[8].value[0].value[0] | 78 |
| DiagnosticReport.contained[8].value[0].unit[0] | % |
| DiagnosticReport.contained[8].value[0].system[0] | http://unitsofmeasure.org |
| DiagnosticReport.contained[8].value[0].code[0] | % |
| DiagnosticReport.contained[9].id[0] | Obs-10 |
| DiagnosticReport.contained[9].meta[0].profile[0] | https://roche.com/fhir/iop/StructureDefinition/rdc-Observation-Report |
| DiagnosticReport.contained[9].status[0] | final |
| DiagnosticReport.contained[9].code[0].coding[0].system[0] | http://loinc.org |
| DiagnosticReport.contained[9].code[0].coding[0].code[0] | 104641-6 |
| DiagnosticReport.contained[9].code[0].coding[0].display[0] | Amount of time, in percent, as measured by CGM (continuous glucose monitor) device, spent below target glucose range, low (TBR-L) 54-69 mg/dL (3.0-3.8 mmol/L) (hypoglycemic) during reporting period |
| DiagnosticReport.contained[9].effective[0].start[0] | 2020-10-15T02:01:00+01:00 |
| DiagnosticReport.contained[9].effective[0].end[0] | 2020-10-15T02:06:00+01:00 |
| DiagnosticReport.contained[9].value[0].value[0] | 5 |
| DiagnosticReport.contained[9].value[0].unit[0] | % |
| DiagnosticReport.contained[9].value[0].system[0] | http://unitsofmeasure.org |
| DiagnosticReport.contained[9].value[0].code[0] | % |
| DiagnosticReport.contained[10].id[0] | Obs-11 |
| DiagnosticReport.contained[10].meta[0].profile[0] | https://roche.com/fhir/iop/StructureDefinition/rdc-Observation-Report |
| DiagnosticReport.contained[10].status[0] | final |
| DiagnosticReport.contained[10].code[0].coding[0].system[0] | http://loinc.org |
| DiagnosticReport.contained[10].code[0].coding[0].code[0] | 104642-4 |
| DiagnosticReport.contained[10].code[0].coding[0].display[0] | Amount of time, in percent, as measured by CGM (continuous glucose monitor) device, spent below target glucose range, very low (TBR-VL) <54 mg/dL (<3.0 mmol/L) (hypoglycemic) during reporting period |
| DiagnosticReport.contained[10].effective[0].start[0] | 2020-10-15T02:01:00+01:00 |
| DiagnosticReport.contained[10].effective[0].end[0] | 2020-10-15T02:06:00+01:00 |
| DiagnosticReport.contained[10].value[0].value[0] | 0 |
| DiagnosticReport.contained[10].value[0].unit[0] | % |
| DiagnosticReport.contained[10].value[0].system[0] | http://unitsofmeasure.org |
| DiagnosticReport.contained[10].value[0].code[0] | % |
| DiagnosticReport.status[0] | final |
| DiagnosticReport.code[0].coding[0].system[0] | https://roche.com/fhir/CodeSystem/general |
| DiagnosticReport.code[0].coding[0].code[0] | R7786-7 |
| DiagnosticReport.code[0].coding[0].display[0] | CGM Ambulatory Glucose Profile (AGP) During Reporting Period |
| DiagnosticReport.subject[0].reference[0] | Patient-Reference |
| DiagnosticReport.effective[0].start[0] | 2023-10-03T06:32:00+01:00 |
| DiagnosticReport.effective[0].end[0] | 2023-10-03T07:30:00+01:00 |
| DiagnosticReport.performer[0].reference[0] | Organization-Reference |
| DiagnosticReport.performer[1].reference[0] | Practitioner-Reference |
| DiagnosticReport.result[0].reference[0] | #Obs-1 |
| DiagnosticReport.result[1].reference[0] | #Obs-2 |
| DiagnosticReport.result[2].reference[0] | #Obs-3 |
| DiagnosticReport.result[3].reference[0] | #Obs-4 |
| DiagnosticReport.result[4].reference[0] | #Obs-5 |
| DiagnosticReport.result[5].reference[0] | #Obs-6 |
| DiagnosticReport.result[6].reference[0] | #Obs-7 |
| DiagnosticReport.result[7].reference[0] | #Obs-8 |
| DiagnosticReport.result[8].reference[0] | #Obs-9 |
| DiagnosticReport.result[9].reference[0] | #Obs-10 |
| DiagnosticReport.result[10].reference[0] | #Obs-11 |
| DiagnosticReport.presentedForm[0].contentType[0] | application/pdf |
| DiagnosticReport.presentedForm[0].data[0] | QUdQIHJlcG9ydA== |
| DiagnosticReport.presentedForm[0].url[0] | https://aws-cloud-location-of-AGP-Report |
| DiagnosticReport.presentedForm[0].hash[0] | 2c9fa2fc8f4fd1b3184821e27dfc0b6960724633 |
| DiagnosticReport.presentedForm[0].title[0] | AGP-Report |
| DiagnosticReport.presentedForm[0].creation[0] | 2023-10-03T07:30:00+01:00 |
